Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Geoffrey A. Block(Renal Associates P. A.), Glenn M. Chertow(Stanford Health Care), Norma J. Ofsthun(Fresenius Medical Care (United States)), J. Michael Lazarus(Groote Schuur Hospital), Preston Klassen(Amgen (United States)), Edmund G. Lowrie(Fresenius Medical Care (United States))
Cited by 2,688
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
|Journal of the American Society of Nephrology|2005|3.4k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
|New England Journal of Medicine|2008|1.8k